QA: JOHNSON & JOHNSON in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2020_JOHNSON_JOHNSON.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000200406, JOHNSON & JOHNSON

  xvar xval
0 AssetsCurrent 45,274,000,000
1 IntangibleAssetsNetIncludingGoodwill 81,282,000,000
2 PropertyPlantAndEquipmentNet 17,658,000,000
3 remainder_Assets 13,514,000,000
4 LiabilitiesCurrent 35,964,000,000
5 LiabilitiesNoncurrent 38,228,000,000
6 remainder_Liabilities 24,065,000,000
7 CostOfGoodsAndServicesSold 27,556,000,000
8 SellingGeneralAndAdministrativeExpense 22,178,000,000
9 ResearchAndDevelopmentExpense 11,355,000,000
10 remainder_Expenses 3,683,000,000
11 remainder_Revenues 82,059,000,000
12 remainder_NetIncome -2,168,000,000
13 remainder_ComprehensiveNetIncome -669,000,000
  yvar yval
0 Assets 157,728,000,000
1 Liabilities 98,257,000,000
2 Expenses 64,772,000,000
3 Revenues 82,059,000,000
4 StockholdersEquity 59,471,000,000
5 NetIncome 15,119,000,000
6 ComprehensiveNetIncome 14,784,500,000
7 BaseVar 202,826,500,000
8 EconomicCapitalRatio 0.915

Edgar->Model Mapping

Feature Distribution

Change over Time